PTC Therapeutics, Inc.

PTCT · Healthcare

$70.56

Markedsværdi: 5.89B USDUdbytteafkast: —
AdvancedEr det et godt tidspunkt at købe PTC Therapeutics, Inc.? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

Trefis4. sep. 2026, 21.23

Own Oracle For The AI Boom? PTC's Story Looks Cleaner

ACCESS Newswire2. sep. 2026, 12.30

Mary Kay Launches Global Brand Platform - Beauty Is More Beautiful Shared(TM) - Celebrating Connection, Community and a New Era of Beauty

PR Newswire27. aug. 2026, 12.00

PTC Therapeutics to Participate in Upcoming Investor Conferences

Zacks24. aug. 2026, 16.53

KROS $20M Takeda Milestone Adds Cash but Revenue Visibility Stays Weak

PR Newswire24. aug. 2026, 12.00

PTC Therapeutics Announces New Sephience™ (sepiapterin) Data Reinforcing Broad Patient Benefits Including Sustained Metabolic Control and Diet Liberalization as well as Consistent Favorable Safety Profile